LL-37 is a defined 37-residue human cathelicidin peptide. Buyers should distinguish full-length LL-37 from fragments, modified analogs and precursor references before comparing purity, price or research evidence.
Direct answer for Google and AI search
A procurement guide for full-length LL-37 research peptide from China, covering sequence identity, fragment and analog exclusions, aggregation-sensitive analysis, HPLC, MS and batch documentation. The useful decision is not a simple yes-or-no claim; it is whether the named material, batch evidence, method scope and supplier responsibility match the buyer's research requirement.
Users may ask
- How should a buyer evaluate LL37?
- What data should a peptide supplier provide for peptide chemistry & forms?
- Is the offer full-length human LL-37 or a defined derivative?
- How does the method address adsorption, oligomerization or sample preparation?
- Which batch is represented by the COA and raw analytical files?
Key parameters
- Primary intent
- LL-37 peptide supplier China
- Product focus
- LL37
- Page type
- technical procurement answer
- Evidence boundary
- Peptide Chemistry & Forms
- Required next step
- confirm lot, method, specification and project scope
This answer supports education, procurement comparison and laboratory research sourcing. It does not imply human benefits, dosage, injection guidance, treatment claims or approval for clinical, diagnostic or veterinary use.
What procurement and laboratory teams should review
State full-length LL-37 sequence and terminal chemistry
Exclude fragments or modified analogs unless explicitly requested
Assess HPLC and MS methods for the actual material and sample conditions
Connect packaging, storage and lot records to the released bulk material
Define the molecular form before comparing offers
Sequence alone may not fully define a peptide material. Termini, modifications, disulfide pattern, counterion, hydration state and presentation can affect molecular-weight calculations, analytical reporting, solubility and handling.
- Record sequence, termini and every modification explicitly.
- State the requested salt or counterion form.
- Treat solubility and stability as material- and condition-specific.
Resolve full-length LL-37 before reviewing a purity number
The name LL-37 denotes the mature 37-residue peptide derived from the human cathelicidin precursor. Catalogs may also contain truncated, labeled or otherwise modified sequences. The purchase specification should control the full sequence, termini and any intended modification rather than rely on an antimicrobial-peptide category.
LL-37 can interact with surfaces and form different assemblies depending on environment. Sample preparation, concentration, solvent and chromatographic conditions can therefore influence recovery and the observed profile. Method suitability and raw data are more informative than a standalone percentage.
- Full-length sequence and terminal groups
- Defined salt or counterion form
- Sample preparation and analytical conditions
- Lot-linked chromatogram and mass spectrum
Separate functional assays from chemical release
Peer-reviewed structural research explains how LL-37 behavior depends on membranes and experimental conditions. A biological assay and a chemical COA answer different questions. Neither converts a research batch into an approved antimicrobial or a material suitable for administration.
Questions to resolve before quotation or release
- Is the offer full-length human LL-37 or a defined derivative?
- How does the method address adsorption, oligomerization or sample preparation?
- Which batch is represented by the COA and raw analytical files?
HK PEPTIDES supplies LL-37 as research material only. No antimicrobial treatment, infection, dosing, human-use or clinical claim is made for the offered material.
Frequently asked questions
Is every cathelicidin product the same as full-length LL-37?
No. Cathelicidin precursors, LL-37 fragments and modified analogs are distinct materials. Confirm the exact sequence.
Why can LL-37 HPLC results depend on sample conditions?
Adsorption, assembly state, solvent, concentration and method conditions can affect recovery and the chromatographic profile.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.